openPR Logo
Press release

New Study Respiratory Syncytial Virus (RSV) Diagnostic Market 2023 : Abott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories and Other Top Key Players Included

11-27-2018 06:31 PM CET | Health & Medicine

Press release from: Allied Market Research

Respiratory Syncytial Virus (RSV) Diagnostic Market

Respiratory Syncytial Virus (RSV) Diagnostic Market

Respiratory syncytial virus (RSV) is a virus that causes respiratory infections such as bronchitis and pneumonia. The number of RSV infections worldwide is increasing. According to the CDC, each year, on an average, RSV leads to the hospitalization of around 1,32,000- 172,000 children below the age of five and the death of around 14,000 adults above the age of 65, in the United States alone. The growing incidence of RSV infection is an important driving force for this market. Because clinical signs of RSV infection are differentiated from other respiratory infections, the need for rapid, specific, and sensitive diagnostic techniques is growing.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/270?utm_source=sank_opr

The current shortage of specific treatment options and the development of vaccines for RSV in the future are the major restraints for this market. Around 99% of RSV associated deaths of children below the age of five are from developing countries, which would lead to an increased demand for diagnostic methods in these countries.

The RSV Diagnostic Market by Technology

The RSV Diagnostic Market is segmented based on technologies such as Molecular Diagnostics, Immunoassays, Monoclonal Antibodies, Differential Light Scattering, Flow Cytometry, Artificial Intelligence, Chromatography, Diagnostic Imaging, Liposomes, Gel Microdroplets, and Others. Among these segments, Molecular Diagnostics have a higher sensitivity and specificity.

The RSV Diagnostic Market by End Users:

The major consumers for diagnostic kits include Hospitals, Nursing homes, Commercial Laboratories, and Public Health Laboratories. Hospitals are the major end user for RSV Diagnostic market. In the year 2000, 402,000 emergency room visits, 2,36,000 hospital outpatient visits and 86,000 hospitalizations of children below the age of five years were a result of RSV infection

The RSV Diagnostic Market by Geographic Distribution

The RSV diagnostic market involves North America, Europe, Asia Pacific and Rest of the World. Currently, the market is dominated by North America and Europe due to the increasing cases of respiratory diseases. However, Asia-Pacific region is an emerging market, as there are increasing incidences of RSV infections and a growing healthcare awareness.

Competitive Analysis

Some of the key players in this market are Abott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories, Beckman Coulter Thermo Fisher Scientific and EMD Millipore. In 2001, Abott and IntelligentMDx (IMDX) entered into an agreement in which IMDx would develop and design real time PCR assays for the Abott m2000 instrument system. The IMDx Flu A/B and RSV test is one such test developed by IntelligentMDx (IMDX) of Cambridge, for Abbott's m2000 molecular diagnostics system. The test is a qualitative Reverse Transcription test for rapid detection of different strains of RSV as well Influenza A, and Influenza B. The test could analyze 94 samples per run and it is fully automated with minimal turnaround time.

High Level Analysis

The report gives an in depth analysis of the RSV diagnostic market. The buyers’ power in this market is high, as there are many suppliers providing diagnostic kits for RSV. The threat of new entrants in the market is low as there are highly differentiated diagnostic kits manufactured by established companies and initial capital investment required is high. The threat of substitutes is low due lack of alternative diagnostic technology for detection of RSV.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/270?utm_source=sank_opr

Key Benefits:

• In depth analysis of current technologies used in the RSV diagnostic enables strategic decision making by stakeholders
• Identification of drivers, restraints and opportunities in the market
• Market segmentation based on technology, end users and geography helps in exploring new business opportunities.
• Analysis of the key players in the market and the technologies developed by them would help in understanding strategies implemented by the competitors

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Study Respiratory Syncytial Virus (RSV) Diagnostic Market 2023 : Abott Laboratories, Becton Dickinson and Company, bioMerieux, Bio-Rad Laboratories and Other Top Key Players Included here

News-ID: 1402886 • Views:

More Releases from Allied Market Research

Automotive Logistics Market on Track to Reach $433.6 Billion by 2031, Exclusive Report by Allied Market Research
Automotive Logistics Market on Track to Reach $433.6 Billion by 2031, Exclusive …
Allied Market Research recently published a report, titled, "Automotive Logistics Market by Service (Warehousing and Transportation), by Type (Finished Vehicles and Automotive Parts), by Mode of Transport (Land, Air, and Sea), and by Distribution Area (Domestic and International): Global Opportunity Analysis and Industry Forecast, 2021-2031." 𝐓𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐭𝐚𝐭𝐞𝐬 𝐭𝐡𝐚𝐭 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐚𝐮𝐭𝐨𝐦𝐨𝐭𝐢𝐯𝐞 𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐬𝐢𝐳𝐞 𝐢𝐬 𝐚𝐧𝐭𝐢𝐜𝐢𝐩𝐚𝐭𝐞𝐝 𝐭𝐨 𝐠𝐫𝐚𝐛 $𝟒𝟑𝟑.𝟔 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏. 𝐓𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟐𝟒𝟏.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧
Exclusive Report by AMR on Refrigerants Market Size and Share, Growing at a CAGR of 7.4% from 2024 to 2030
Exclusive Report by AMR on Refrigerants Market Size and Share, Growing at a CAGR …
The global refrigerants market generated $20.6 billion in 2020, and is projected to reach $42.0 billion by 2030, witnessing a CAGR of 7.4% from 2021 to 2030. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape. Refrigerants are substances that are used in refrigeration and air conditioning systems to transfer heat. They are typically volatile liquids or gases that can easily
Air Defense Systems Market Worth $78.2 Billion Globally by 2031 | Allied Market Research
Air Defense Systems Market Worth $78.2 Billion Globally by 2031 | Allied Market …
Allied Market Research recently published a report, titled, "Air Defense Systems Market by Component (Weapon System, Fire Control System, Command and Control System, Others), by Range (Short Range Air Defense System, Medium Range Air Defense System, Long Range Air Defense System), by Platform (Ground, Airborne, Naval), by Type (Missile Defense System, Anti-Aircraft, Counter Rocket, Artillery, and Mortar System): Global Opportunity Analysis and Industry Forecast, 2021-2031". As per the report, the
The Cloud Seeding Market Set to Reach $192.77 Million Globally by 2031
The Cloud Seeding Market Set to Reach $192.77 Million Globally by 2031
Allied Market Research published a report, titled, "Cloud Seeding Market by Type (Aerial Cloud Seeding, Ground Based Cloud Seeding), by Application (Increasing Precipitation, Mitigating Hail Damage, Dispersing Fog), by Flare (End Burning Flares, Ejection Flares, Automatic and Remote Based Generator, Manual Generator, Flare Trees), by Seeding Technique (Hygroscopic, Glaciogenic ): Global Opportunity Analysis and Industry Forecast, 2021-2031". According to the report, the global Cloud Seeding industry generated $120.35 million in

All 5 Releases


More Releases for RSV

RSV Diagnostics Market | Pin-Point Analysis for Changing Competitive Dynamics
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
Global RSV Diagnostics Market 2018-2025 bio Mérieux, Abbott, Roche, BD
A market study "Global RSV Diagnostics Market" examines the performance of the RSV Diagnostics market 2018. It encloses an in-depth Research of the RSV Diagnostics market state and the competitive landscape globally. This report analyzes the potential of RSV Diagnostics market in the present and the future prospects from various angles in detail. The Global RSV Diagnostics Market 2018 report includes RSV Diagnostics market Revenue, market Share, RSV Diagnostics industry volume,
RSV Diagnostics Market Trend | Industry Analysis Report, 2019
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
RSV Diagnostics Market Set to Surge Significantly During 2019
Human respiratory syncytial virus (RSV) is a virus that commonly causes lower respiratory tract infection. Human respiratory syncytial virus infections are acquired during hospital visits. Infants and in young children are more prone to human respiratory syncytial virus (RSV) infection. RSV infections affect lungs and respiratory tract of an individual. In premature babies and children with previous presence of diseases, RSV infections affect heart and immune systems as well resulting
Global Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics Sales Market R …
Qyresearchreports include new market research report "Global Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics Sales Market Report 2017" to its huge collection of research reports. This research report gives a definitive review on the Pediatric Respiratory Syncytial Virus ( RSV) Prophylactics as in light of a segmented pattern. Entry variables managed in the report incorporate the distinctive services or products offered by the market players alongside the free market activity scales
OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis An …
Summary Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense ribonucleic acid (RNA) pneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate from a laboratory chimpanzee displaying symptoms of the common cold, and later from infants suffering from respiratory disease. RSV can cause upper respiratory tract infections (the common cold) and is the most important cause of lower respiratory tract infections, such